CORYFIN GOLA 20CPR OROD 0.25MG

CORYFIN GOLA 0.25 MG ORODISPERABLE

active ingredients

Each available gold tablet contains: dequaline chloride 0.25 mg. Excipient(s) with known effects: sucrose. For the full list of excipients see the paragraph 6.1.

Excellent

Capuchin; sucrose; arabic rubber; vanillin; menthol; talc; magnesium stearate; compound aroma.

Therapeutic indications

Disinfectant of the oral cable.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1.

Population

Population In pharyngeal and tonsillary inflammations from 3 to 5 tablets available daily. Tablets should slowly melt in the mouth. Do not exceed the recommended doses.

Conservation

None.

Warnings

Pediatric population For the presence of menthol in children under two years with laryngeospasm or convulsions, consult your doctor before using the product. Use similar caution in children up to six years of age. This product contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose–galactose mal absorption, or isomaltase sucrasis failure, should not take this medicine. This medicine contains 1,2 g sucrose per tablet. To be considered in people with diabetes mellitus.

Interactions

No notes.

Effects

Hypersensitivity phenomena can occur (skin rashes etc.). Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at: www.agenziafarmaco.gov.it/it/responsabili.

Overdosing

No known overdose symptoms.

During pregnancy, the use for long periods must only be done by prescription; not to be used in the last month.

Source: Farmadati